Katia Varani Selected Research

Katia Varani Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 09/2003
18	Inflammation (Inflammations) 01/2023 - 01/2008
13	Pain (Aches) 01/2022 - 08/2002
12	Hypoxia (Hypoxemia) 09/2019 - 10/2005
9	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 11/2003
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 07/2020
8	Parkinson Disease (Parkinson's Disease) 04/2022 - 04/2003
7	Neuroinflammatory Diseases 01/2023 - 01/2016
6	Rheumatoid Arthritis 01/2018 - 10/2009
6	Catalepsy 01/2017 - 10/2006
6	Melanoma (Melanoma, Malignant) 01/2017 - 10/2002
5	Asthma (Bronchial Asthma) 04/2015 - 01/2008
4	Huntington Disease (Huntington's Disease) 01/2022 - 11/2003
4	Chronic Pain 11/2020 - 06/2013
4	Seizures (Absence Seizure) 01/2017 - 06/2016
4	Arthritis (Polyarthritis) 01/2013 - 01/2008
3	Central Nervous System Diseases (CNS Diseases) 10/2023 - 01/2022
3	Neuralgia (Stump Neuralgia) 01/2019 - 07/2012
3	Ischemia 01/2017 - 10/2013
3	Abnormal Reflex (Hyperreflexia) 01/2017 - 06/2016
3	Breast Neoplasms (Breast Cancer) 01/2017 - 02/2005
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2015 - 02/2006
3	Glaucoma 12/2011 - 01/2008
3	Glioblastoma (Glioblastoma Multiforme) 05/2010 - 06/2006
2	Memory Disorders (Memory Loss) 01/2023 - 04/2022
2	Cognitive Dysfunction 01/2023 - 01/2022
2	Brain Ischemia (Cerebral Ischemia) 12/2022 - 01/2017
2	Brain Injuries (Brain Injury) 12/2022 - 10/2013
2	Stroke (Strokes) 01/2022 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 09/2013
2	Epilepsy (Aura) 01/2022 - 01/2016
2	Multiple Sclerosis 01/2022 - 08/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2020
2	Malignant Mesothelioma 01/2021 - 02/2011
2	Ischemic Stroke 01/2020 - 03/2015
2	Pheochromocytoma 09/2019 - 02/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 11/2012
2	Cancer Pain 01/2018 - 01/2013
2	Autosomal Dominant Polycystic Kidney (ADPKD) 04/2017 - 06/2009
2	Fibrosis (Cirrhosis) 01/2017 - 03/2009
2	Diabetic Neuropathies (Diabetic Neuropathy) 05/2016 - 06/2013
2	Hyperalgesia 05/2016 - 06/2013
2	Bone Neoplasms (Bone Cancer) 06/2013 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2013 - 06/2007
2	Colonic Neoplasms (Colon Cancer) 08/2007 - 06/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024

Drug/Important Bio-Agent (IBA)

50	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2023 - 08/2002
36	Adenosine (Adenocard)FDA LinkGeneric 12/2022 - 10/2002
9	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2005
7	LigandsIBA 04/2022 - 08/2002
7	CytokinesIBA 01/2021 - 02/2003
6	EnzymesIBA 01/2023 - 03/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 06/2006
5	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2021 - 06/2007
5	NucleosidesIBA 01/2017 - 10/2003
4	Phosphotransferases (Kinase)IBA 04/2022 - 10/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 10/2009
3	EndocannabinoidsIBA 01/2023 - 01/2022
3	Caffeine (No Doz)FDA LinkGeneric 01/2023 - 08/2007
3	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2022
3	Peptides (Polypeptides)IBA 05/2022 - 01/2022
3	Purinergic P1 Receptor AntagonistsIBA 04/2022 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2003
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2010
3	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2017 - 10/2006
3	Purine NucleosidesIBA 01/2017 - 10/2005
3	Streptozocin (Streptozotocin)FDA Link 05/2016 - 06/2013
3	Formaldehyde (Formol)FDA Link 06/2014 - 06/2012
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2013 - 01/2010
3	NF-kappa B (NF-kB)IBA 01/2012 - 10/2009
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2023 - 01/2023
2	Glutamic Acid (Glutamate)FDA Link 04/2022 - 01/2020
2	Leucine (L-Leucine)FDA Link 04/2022 - 01/2017
2	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 01/2010
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2007
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2019 - 06/2007
2	Oxygen (Dioxygen)IBA 01/2017 - 10/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2015
2	Morphine (MS Contin)FDA LinkGeneric 12/2016 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 12/2016 - 03/2009
2	2- amino- 4- ((4- (phenyl)piperazin- 1- yl)methyl)- 5- (4- fluorophenyl)thiophen- 3- yl)- (4- chlorophenyl)methanoneIBA 12/2016 - 06/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016 - 11/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 10/2009
2	Transcription Factors (Transcription Factor)IBA 11/2015 - 08/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2015 - 10/2013
2	D-Aspartic Acid (D Aspartate)IBA 06/2014 - 06/2013
2	Analgesics (Analgesic Drugs)IBA 06/2014 - 06/2013
2	Opioid Analgesics (Opioids)IBA 08/2013 - 08/2012
2	CannabinoidsIBA 06/2013 - 08/2012
2	Interleukin-8 (Interleukin 8)IBA 10/2009 - 08/2007
2	Adenosine Triphosphate (ATP)IBA 06/2009 - 03/2007
2	Mitogen-Activated Protein Kinase 3IBA 07/2007 - 05/2005
2	Adenosine DeaminaseIBA 07/2007 - 06/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2007 - 09/2003
1	Histone Deacetylase InhibitorsIBA 04/2024
1	Neuroprotective AgentsIBA 01/2023
1	palmidrolIBA 01/2023

Therapy/Procedure

14	Therapeutics 10/2023 - 09/2003
2	Induced Hypothermia 01/2017 - 10/2016
2	Drug Therapy (Chemotherapy) 07/2007 - 10/2003